HK Stock MarketDetailed Quotes

02407 GAUSH MEDITECH

Watchlist
  • 10.720
  • -0.020-0.19%
Trading Dec 2 14:35 CST
1.59BMarket Cap15.95P/E (TTM)

GAUSH MEDITECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-8.37%642.03M
12.16%1.41B
21.26%700.7M
-3.42%1.25B
-0.12%577.87M
34.94%1.3B
66.20%578.57M
-13.06%962.08M
--348.11M
19.43%1.11B
Operating income
-8.37%642.03M
12.16%1.41B
21.26%700.7M
-3.42%1.25B
-0.12%577.87M
34.94%1.3B
66.20%578.57M
-13.06%962.08M
348.11M
19.43%1.11B
Cost of sales
0.41%-343.68M
-13.71%-714.64M
-16.34%-345.1M
8.76%-628.45M
3.93%-296.63M
-30.97%-688.75M
-61.06%-308.77M
18.25%-525.9M
---191.71M
-17.42%-643.31M
Operating expenses
0.41%-343.68M
-13.71%-714.64M
-16.34%-345.1M
8.76%-628.45M
3.93%-296.63M
-30.97%-688.75M
-61.06%-308.77M
18.25%-525.9M
-191.71M
-17.42%-643.31M
Gross profit
-16.10%298.35M
10.60%691.6M
26.44%355.61M
2.60%625.34M
4.24%281.24M
39.73%609.47M
72.50%269.8M
-5.86%436.18M
156.4M
22.34%463.35M
Selling expenses
4.48%-115.48M
-32.52%-248.83M
-34.14%-120.89M
0.90%-187.77M
-6.92%-90.12M
-17.84%-189.47M
-32.57%-84.29M
19.81%-160.79M
---63.58M
-3.13%-200.52M
Administrative expenses
-17.73%-73.61M
11.48%-129.38M
10.41%-62.53M
-11.14%-146.17M
-18.47%-69.79M
-45.96%-131.52M
-119.00%-58.91M
-14.87%-90.11M
---26.9M
-12.73%-78.44M
Research and development expenses
-34.61%-35.14M
-28.70%-52.88M
-16.46%-26.11M
-74.80%-41.09M
-138.98%-22.42M
-648.84%-23.51M
-546.01%-9.38M
-18.05%-3.14M
---1.45M
-12.81%-2.66M
Revaluation surplus
----
----
----
18.15%-307.43M
63.63%-36.1M
-481.15%-375.61M
---99.25M
62.67%-64.63M
----
---173.15M
-Changes in the fair value of other assets
----
----
----
18.15%-307.43M
63.63%-36.1M
-481.15%-375.61M
---99.25M
62.67%-64.63M
----
---173.15M
Special items of operating profit
-75.44%4.87M
121.58%37.84M
126.69%19.82M
-411.96%-175.3M
-339.65%-74.26M
61.84%56.19M
185.38%30.99M
1,196.68%34.72M
---36.3M
97.40%-3.17M
Operating profit
-52.39%79M
228.37%298.34M
1,549.27%165.91M
-326.92%-232.41M
-123.38%-11.45M
-135.76%-54.44M
73.75%48.96M
2,714.92%152.23M
28.18M
157.35%5.41M
Financing cost
13.01%-20.6M
-18.57%-50.61M
-14.42%-23.68M
48.90%-42.68M
65.77%-20.7M
-2,615.38%-83.53M
-9,606.58%-60.47M
5.62%-3.08M
---623K
-6.54%-3.26M
Earning before tax
-58.94%58.4M
190.05%247.74M
542.43%142.23M
-99.40%-275.09M
-179.25%-32.15M
-192.50%-137.96M
-141.78%-11.51M
6,840.67%149.16M
27.56M
117.21%2.15M
Tax
1.07%-31.47M
3.60%-74.82M
-50.63%-31.81M
-44.79%-77.62M
8.48%-21.12M
-5.91%-53.61M
-57.65%-23.07M
-25.99%-50.62M
---14.64M
-53.83%-40.18M
After-tax profit from continuing operations
-75.61%26.93M
149.02%172.91M
307.31%110.42M
-84.12%-352.71M
-54.01%-53.26M
-294.41%-191.57M
-367.69%-34.59M
359.13%98.54M
12.92M
1.50%-38.03M
Earning after tax
-75.61%26.93M
149.02%172.91M
307.31%110.42M
-84.12%-352.71M
-54.01%-53.26M
-294.41%-191.57M
-367.69%-34.59M
359.13%98.54M
12.92M
1.50%-38.03M
Minority profit
-76.69%-1.55M
80.31%-609K
58.92%-875K
-175.18%-3.09M
-1,631.71%-2.13M
-35.59%-1.12M
67.11%-123K
15.84%-829K
---374K
18.73%-985K
Profit attributable to shareholders
-74.42%28.47M
149.63%173.52M
317.66%111.3M
-83.58%-349.62M
-48.38%-51.13M
-291.66%-190.45M
-359.23%-34.46M
368.26%99.37M
13.29M
0.94%-37.04M
Basic earnings per share
-74.67%0.19
132.41%1.17
238.89%0.75
-81.41%-3.61
-58.82%-0.54
-311.70%-1.99
-361.54%-0.34
376.47%0.94
0.13
0.00%-0.34
Diluted earnings per share
-74.67%0.19
0.75
-361.54%-0.34
376.47%0.94
0.13
0.00%-0.34
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -8.37%642.03M12.16%1.41B21.26%700.7M-3.42%1.25B-0.12%577.87M34.94%1.3B66.20%578.57M-13.06%962.08M--348.11M19.43%1.11B
Operating income -8.37%642.03M12.16%1.41B21.26%700.7M-3.42%1.25B-0.12%577.87M34.94%1.3B66.20%578.57M-13.06%962.08M348.11M19.43%1.11B
Cost of sales 0.41%-343.68M-13.71%-714.64M-16.34%-345.1M8.76%-628.45M3.93%-296.63M-30.97%-688.75M-61.06%-308.77M18.25%-525.9M---191.71M-17.42%-643.31M
Operating expenses 0.41%-343.68M-13.71%-714.64M-16.34%-345.1M8.76%-628.45M3.93%-296.63M-30.97%-688.75M-61.06%-308.77M18.25%-525.9M-191.71M-17.42%-643.31M
Gross profit -16.10%298.35M10.60%691.6M26.44%355.61M2.60%625.34M4.24%281.24M39.73%609.47M72.50%269.8M-5.86%436.18M156.4M22.34%463.35M
Selling expenses 4.48%-115.48M-32.52%-248.83M-34.14%-120.89M0.90%-187.77M-6.92%-90.12M-17.84%-189.47M-32.57%-84.29M19.81%-160.79M---63.58M-3.13%-200.52M
Administrative expenses -17.73%-73.61M11.48%-129.38M10.41%-62.53M-11.14%-146.17M-18.47%-69.79M-45.96%-131.52M-119.00%-58.91M-14.87%-90.11M---26.9M-12.73%-78.44M
Research and development expenses -34.61%-35.14M-28.70%-52.88M-16.46%-26.11M-74.80%-41.09M-138.98%-22.42M-648.84%-23.51M-546.01%-9.38M-18.05%-3.14M---1.45M-12.81%-2.66M
Revaluation surplus ------------18.15%-307.43M63.63%-36.1M-481.15%-375.61M---99.25M62.67%-64.63M-------173.15M
-Changes in the fair value of other assets ------------18.15%-307.43M63.63%-36.1M-481.15%-375.61M---99.25M62.67%-64.63M-------173.15M
Special items of operating profit -75.44%4.87M121.58%37.84M126.69%19.82M-411.96%-175.3M-339.65%-74.26M61.84%56.19M185.38%30.99M1,196.68%34.72M---36.3M97.40%-3.17M
Operating profit -52.39%79M228.37%298.34M1,549.27%165.91M-326.92%-232.41M-123.38%-11.45M-135.76%-54.44M73.75%48.96M2,714.92%152.23M28.18M157.35%5.41M
Financing cost 13.01%-20.6M-18.57%-50.61M-14.42%-23.68M48.90%-42.68M65.77%-20.7M-2,615.38%-83.53M-9,606.58%-60.47M5.62%-3.08M---623K-6.54%-3.26M
Earning before tax -58.94%58.4M190.05%247.74M542.43%142.23M-99.40%-275.09M-179.25%-32.15M-192.50%-137.96M-141.78%-11.51M6,840.67%149.16M27.56M117.21%2.15M
Tax 1.07%-31.47M3.60%-74.82M-50.63%-31.81M-44.79%-77.62M8.48%-21.12M-5.91%-53.61M-57.65%-23.07M-25.99%-50.62M---14.64M-53.83%-40.18M
After-tax profit from continuing operations -75.61%26.93M149.02%172.91M307.31%110.42M-84.12%-352.71M-54.01%-53.26M-294.41%-191.57M-367.69%-34.59M359.13%98.54M12.92M1.50%-38.03M
Earning after tax -75.61%26.93M149.02%172.91M307.31%110.42M-84.12%-352.71M-54.01%-53.26M-294.41%-191.57M-367.69%-34.59M359.13%98.54M12.92M1.50%-38.03M
Minority profit -76.69%-1.55M80.31%-609K58.92%-875K-175.18%-3.09M-1,631.71%-2.13M-35.59%-1.12M67.11%-123K15.84%-829K---374K18.73%-985K
Profit attributable to shareholders -74.42%28.47M149.63%173.52M317.66%111.3M-83.58%-349.62M-48.38%-51.13M-291.66%-190.45M-359.23%-34.46M368.26%99.37M13.29M0.94%-37.04M
Basic earnings per share -74.67%0.19132.41%1.17238.89%0.75-81.41%-3.61-58.82%-0.54-311.70%-1.99-361.54%-0.34376.47%0.940.130.00%-0.34
Diluted earnings per share -74.67%0.190.75-361.54%-0.34376.47%0.940.130.00%-0.34
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data